News summary

Lara-Gut Behrami invests in longevity startup Avea

Source: Startupticker.ch • Published: 20 Oct 2026, 00:00

Summarized by Masters of Longevity from Startupticker.ch.

Lara Gut-Behrami’s investment in a Swiss longevity supplement brand — an article about a four-year investor–advisor partnership focused on female performance and recovery.

Lara-Gut Behrami invests in longevity startup Avea
Key Takeaways
  • Lara-Gut Behrami is investing in Avea and will serve on its advisory board and leadership roles.
  • The four-year partnership will target female health, performance, recovery, and long-term sustainable performance.
  • Avea offers science-oriented supplements, including NMN for NAD+ support and a hormone-free MenoSpan formula.
Read the full article at Startupticker.ch ↗

Continue exploring

Recommended MoL Picks

MoL PickCreatine and Cancer: Why New Mouse Studies Point in Opposite DirectionsCreatine strengthened antitumour immune cells in one mouse study—and promoted metastasis through platelets in another. The apparent contradiction reveals why neither result is a supplement recommendation.MoL PickApple Brings Longevity to the Wrist. What Will It Change?Apple’s new Health Age, readiness and movement tools bring long-term health into everyday view. The opportunity is turning that information into useful action.MoL PickNucleotides and Longevity: Is the Evidence Ready?They help build DNA and keep cells working. Early human studies make nucleotide supplements interesting—but leave important questions about healthy ageing unanswered. Yet.